Back to Search
JOHN SHAUGHNESSY, PHARM.D., RPH.
PHARM.D., RPH.
Pharmacist
NPI: 1982954319Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
11984(SC)
Research & Publications (20)
Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
PMID 19273554·Infect Immun·2009
8-other
Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
PMID 17489983·Br J Haematol·2007
8-other
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
PMID 17105813·Blood·2007
8-other
Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
PMID 16399589·Biol Blood Marrow Transplant·2006
6-review
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
PMID 17049078·Cell Div·2006
8-other
Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma.
PMID 16188652·Hematology·2005
8-other
Gene expression profiling and multiple myeloma.
PMID 16026736·Best Pract Res Clin Haematol·2005
6-review
Primer on medical genomics. Part IX: scientific and clinical applications of DNA microarrays--multiple myeloma as a disease model.
PMID 12962165·Mayo Clin Proc·2003
6-review
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.
PMID 12492575·Br J Haematol·2003
8-other
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression.
PMID 12531801·Blood·2003
4-observational
Global gene expression profiling in the study of multiple myeloma.
PMID 12731663·Int J Hematol·2003
6-review
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling.
PMID 12846813·Immunol Rev·2003
6-review
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma.
PMID 12430902·Int J Hematol·2002
8-other
Developmental therapeutics for multiple myeloma--a road map for the future.
PMID 11486318·Semin Hematol·2001
8-other
Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
PMID 11418483·Blood·2001
8-other
High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH.
PMID 10942398·Blood·2000
8-other
The molecular characterization and clinical management of multiple myeloma in the post-genome era.
PMID 19657360·Leukemia·2009
6-review
Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.
PMID 19657367·Leukemia·2009
8-other
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
PMID 19636021·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1141 STATE PARK ROAD
GREENVILLE, SC 29609 - Phone
- (864) 240-7421
Quick Facts
- NPI
- 1982954319
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile